Longer Time Until Recurrence Associated With Better Melanoma Outcomes
Source: CureToday, October 2024
An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved progression and survival.
Among patients with advanced melanoma, a longer time until disease recurrence was associated with post-recurrence progression and survival benefits, researchers have found.
“It essentially means that if you are on an adjuvant [postsurgical] immunotherapy, then the longer that you have until relapse, obviously that sets you up for a much better long-term outcome,” said Dr. Jason Luke, associate director of clinical research of the UPMC Hillman Cancer Center in Pittsburgh and a member of the CURE® advisory board, in an interview.